A dimer comprising a mutated neublastin polypeptide coupled to a polymer is disclosed. Such dimers exhibit prolonged bioavailability and, in preferred embodiments, prolonged biological activity relative to wild-type forms of neublastin.
Web www.patentalert.com
< Compositions and Methods For Treatment of Disorders of Protein Aggregation
> Isolation, Purification and Synthesis of Procyanidin B2 and Uses Thereof
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT